TY - JOUR
T1 - Atypisches Vorhofflattern
T2 - Diagnostik und Therapie
AU - Kottmaier, Marc
AU - Bourier, Felix
AU - Busch, Sonia
AU - Sommer, Philipp
AU - Maurer, Tilman
AU - Althoff, Till
AU - Shin, Dong In
AU - Duncker, David
AU - Johnson, Victoria
AU - Estner, Heidi
AU - Rillig, Andreas
AU - Iden, Leon
AU - Tilz, Roland
AU - Metzner, Andreas
AU - Chun, K. R.Julian
AU - Steven, Daniel
AU - Jansen, Henning
AU - Jadidi, Amir
AU - Ewertsen, Christian
AU - Reents, Tilko
N1 - Funding Information:
A. Rillig: consultant fees and travel grants or study support form Biosense Webster, Medtronik, EPD/Philips, Cardiofocus, Ablamap and Abbott. D. Steven: speakers honoraria from Abbott, Boston Scientific and Biosense Webster and research grants from Medtronic, Abbott and Biosense Webster. T. Althoff: research grants for investigator-initiated trials from Biosense Webster. T. Maurer: Speaker honoraria/travel grants from Abbott, Biosense Webster, Medtronic, and Philips. V. Johnson: speaker and travel fee, fellowship Grant von Abbott Medical, Biotronik SE, Boston Scientific, Medtronic, Pfizer, BMS, Zoll, Astra Zeneca, Boehringer Ingelheim and Bayer Vital GmbH. L. Iden: consultant honoraria/lecture fees from Biosense Webster, Biotronik, Medtronic. D. Duncker: speaker honoraria from Abbott, Astra Zeneca, Bayer, Biotronik, Boehringer Ingelheim, Boston Scientific, Bristol Myers Squibb, CVRx, Medtronic, Pfizer, Zoll. P. Sommer: Advisory Board Abbott, Biosense Webster, Boston Scientific, and Medtronic. M. Kottmaier: consultant, speaker and travel fee Abbott, Biosense Webster, Boston Scientific. T. Reents: consultant, speaker and travel fee Abbott, Biosense Webster, Boston Scientific. F. Bourier: consultant, speaker and travel fee Abbott, Biosense Webster, Boston Scientific. R. Tilz: received travel grants from St. Jude Medical, Biosense Webster, Daiichi Sankyo, SentreHeart and Speaker’s Bureau Honoraria from Biosense Webster, Boston scientific, Abbott, Bristol-Myers Squibb, Bayer, Sanofi Aventis, and research grants by Cardiofocus, Boston Scientific and Lifetech. A. Metzner: Advisory board: Medtronic, Biosense Webster; lecture honoraria: Medtronic, Biosense Webster, Boston Scientific, Cardiofocus, Bayer. S. Busch, D.-I. Shin, H. Estner, K. R. J. Chun, H. Jansen, A. Jadidi und C. Ewertsen geben an, dass kein Interessenkonflikt besteht.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/9
Y1 - 2022/9
N2 - In contrast to typical atrial flutter, atypical atrial flutter is a heterogeneous group of right and left atrial macro- or localized reentry tachycardias whose critical component for maintaining tachycardia is not the cavotricuspid isthmus. Atypical atrial flutter occurs more frequently after previous catheter ablation and after cardiac surgery. The intraprocedural success rate during ablation is high, although the recurrence rate depends on structural changes in the atria as well as the underlying mechanism. This article provides an overview of the mechanisms as well as mapping and ablation strategies of the most common forms of right and left atrial atypical atrial flutter. This article is part of the “EP Basics” series for targeted continuing education in invasive electrophysiology. Basics, clinic and therapy of atypical atrial flutter are presented with focus on clinically relevant aspects. Procedures and findings of invasive electrophysiological diagnostics and ablation treatment are the focus of this article.
AB - In contrast to typical atrial flutter, atypical atrial flutter is a heterogeneous group of right and left atrial macro- or localized reentry tachycardias whose critical component for maintaining tachycardia is not the cavotricuspid isthmus. Atypical atrial flutter occurs more frequently after previous catheter ablation and after cardiac surgery. The intraprocedural success rate during ablation is high, although the recurrence rate depends on structural changes in the atria as well as the underlying mechanism. This article provides an overview of the mechanisms as well as mapping and ablation strategies of the most common forms of right and left atrial atypical atrial flutter. This article is part of the “EP Basics” series for targeted continuing education in invasive electrophysiology. Basics, clinic and therapy of atypical atrial flutter are presented with focus on clinically relevant aspects. Procedures and findings of invasive electrophysiological diagnostics and ablation treatment are the focus of this article.
UR - http://www.scopus.com/inward/record.url?scp=85136517174&partnerID=8YFLogxK
U2 - 10.1007/s00399-022-00887-3
DO - 10.1007/s00399-022-00887-3
M3 - Zeitschriftenaufsätze
C2 - 35986095
AN - SCOPUS:85136517174
SN - 0938-7412
VL - 33
SP - 341
EP - 350
JO - Herzschrittmachertherapie und Elektrophysiologie
JF - Herzschrittmachertherapie und Elektrophysiologie
IS - 3
ER -